Please use this identifier to cite or link to this item: http://hdl.handle.net/11455/68801
標題: HPLC separation of ibuprofen and mefenamic acid using molecularly imprinted polymer as stationary phase
作者: Hung, C.Y.
Huang, Y.T.
Huang, H.H.
Hwang, C.C.
關鍵字: performance liquid-chromatography
nonsteroidal antiinflammatory drugs
spectra derivative spectrophotometry
pharmaceutical formulations
human
plasma
hydrochlorothiazide
elution
urine
期刊/報告no:: E-Polymers.
摘要: A simple high-performance liquid chromatographic method for the assay of ibuprofen and mefenamic acid in tablets is described. This method was developed by using self-prepared molecularly imprinted polymers (MIPs) as the stationary phase. MIPs are synthesized using non-covalent method by the free radical polymerization of template, functional monomer and an excess of crosslink monomers resulting in organic materials. The resulting bulk material was then ground into 25 similar to 44 mu m particles and packed into analytical columns. The effect of functional monomers/crosslinking ratio and the concentration of acetonitrile in the mobile phase were studied. Ibuprofen and mefenamic acid were efficiently resolved on the polymer. The retention time of ibuprofen and mefenamic acid were approximately 19.69 +/- 0.36 min and 46.27 +/- 1.23 min, respectively. Linearity was observed from 3.13-8.33 g/l for ibuprofen and 0.3-0.9 g/l for mefenamic acid, with the coefficients of determination (r(2)) of 0.9977 and 0.9958. The limits of detection (LOD) of ibuprofen and mefenamic acid were found to be respectively 0.42 g/l and 0.06 g/l, while the limits of quantitation (LOQ) were 1.41 g/l and 0.20 g/l, respectively. The self-prepared MIP was successfully applied to the commercial tablet analysis and the result showed a good accuracy with -1.33 similar to -1.8% and -0.8 similar to +1.33% for ibuprofen and mefenamic acid.
URI: http://hdl.handle.net/11455/68801
ISSN: 1618-7229
Appears in Collections:期刊論文

文件中的檔案:

取得全文請前往華藝線上圖書館



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.